MetLife Series A Preferred Stock
MET.PRA
5 hedge funds and large institutions have $6.85M invested in MetLife Series A Preferred Stock in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.
0.2% less ownership
Funds ownership: 1.44% → 1.24% (-0.2%)
29% less funds holding
Funds holding: 7 → 5 (-2)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $1.11M
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Summit Financial
Parsippany,
New Jersey
|
-$963K |
| 2 |
Strategic Investment Solutions
Orland Park,
Illinois
|
-$95.2K |
| 3 |
Tower Bridge Advisors
Conshohocken,
Pennsylvania
|
-$50.8K |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$4.29K |
MET.PRA Hedge Fund Activity: Q4 2023 in Review
5 of the 6,876 institutional investors tracked by Wall St. Rank reported a position in MetLife Series A Preferred Stock (MET.PRA) for Q4 2023, worth a combined $6.85M — down 14% from $7.98M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of MET.PRA and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 0 added.
The largest seller was Summit Financial, exiting entirely with an estimated $963K sold.
- 5 institutional investors held MetLife Series A Preferred Stock (MET.PRA) as of Q4 2023, down from 7 in Q3 2023.
- Funds reported $6.85M of MetLife Series A Preferred Stock stock for Q4 2023, down 14% quarter-over-quarter.
- 0 funds opened new MetLife Series A Preferred Stock positions in Q4 2023 and 2 closed out, a net change of -2 holders.
- The largest MetLife Series A Preferred Stock seller in Q4 2023 was Summit Financial, an estimated $963K sold.
Based on aggregated 13F filings for Q4 2023.